P04.69 Differential microglia - glioma cell interaction during tumor progression

Por Grosch, J, Osswald, M, Berghoff, A S, Wick, W, Winkler, F
Publicado no Neuro Oncol (2018)

P02.08 Visualizing tumor cell - lymphocyte interactions in the brain metastatic cascade using in vivo two photon microscopy

Por Piechutta, M, Berghoff, A S, Karreman, M A, Gunkel, K, Wick, W, Winkler, F
Publicado no Neuro Oncol (2018)

P02.13 Before requiring a cure: towards preventing the outgrowth of brain metastases

Por Karreman, M A, Berghoff, A S, Gunkel, K, Piechutta, M, Feinauer, M, Wick, W, Winkler, F
Publicado no Neuro Oncol (2018)

OS2.2 Paracrine impairment of antitumor T cell immunity by IDH1-mutant gliomas

Por Bunse, L., Bunse, T., Pusch, S., Sahm, F., Sanghvi, K., Berghoff, A., Steadman, M., Niemeyer, B., Wick, W., Platten, M.
Publicado no Neuro Oncol (2016)

P05.51 Prognostic impact of genetic alterations and methylation class in meningioma

Por Berghoff, A S, Ricken, G, Rajky, U, Marosi, C, Hainfellner, J A, von Deimling, A, Sahm, F, Preusser, M
Publicado no Neuro Oncol (2018)

P02.02 PRELIMINARY CHARACTERIZATION OF THE IMMUNE RESPONSE IN GLIOBLASTOMA BEFORE AND AFTER FIRST-LINE THERAPY

Por Kiesel, B., Millesi, M., Berghoff, A.S., Hainfellner, J.A., Widhalm, G., Marosi, C., Höftberger, R., Haberler, C., Woehrer, A.
Publicado em 2014

Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations

Por Balendran, S., Liebmann-Reindl, S., Berghoff, A. S., Reischer, T., Popitsch, N., Geier, C. B., Kenner, L., Birner, P., Streubel, B., Preusser, M.
Publicado no J Neurooncol (2017)

P04.09 Tumor infiltrating lymphocytes and programmed death ligand 1 (PD-L1) expression in diffuse and anaplastic gliomas

Por Berghoff, A. S., Kiesel, B., Widhalm, G., Wilhelm, D., Rajky, O., Kurscheid, S., Hegi, M., Wöhrer, A., Marosi, C., Preusser, M.
Publicado no Neuro Oncol (2016)

O6.02 ANALYSIS OF PD1 AND PD-L1 EXPRESSION IN GLIOBLASTOMA

Por Berghoff, A.S., Kiesel, B., Widhalm, G., Wöhrer, A., Dieckmann, K., Filipits, M., Marosi, C., Hainfellner, J.A., Preusser, M., Wick, W.
Publicado em 2014

O1.03 DENSITY OF TUMOR INFILTRATING LYMPHOCYTES CORRELATES WITH BRAIN EDEMA AND OVERALL SURVIVAL IN BRAIN METASTASES

Por Berghoff, A.S., Wöhrer, A., Hackl, M., Pichler, J., Hutterer, M., Widhalm, G., Dieckmann, K., Prayer, D., Hainfellner, J.A., Preusser, M.
Publicado em 2014

P14.25 18F-fluordesoxyglucose positron emission tomography (FDG-PET/CT) the detection of the primary lesion and staging in brain metastasis (BM) patients with cancer of unknown pri...

Por Wolpert, F., Le Rhun, E., Berghoff, A., Rushing, E., Andratschke, N., Regli, L., Reyns, N., Kaufmann, P., Preusser, M., Weller, M.
Publicado no Neuro Oncol (2017)

OS7.1 Identification and characterization of brain metastasis initiating cells

Por Liao, Y., Berghoff, A. S., Osswald, M., Ilhan-Mutlu, A., Gil, B., Thome, C., Ratliff, M., Steeg, P., Wick, W., Winkler, F.
Publicado no Neuro Oncol (2016)

P04.03 Analysis of the inflammatory tumor microenvironment in meningeal malignancies

Por Berghoff, A. S., Kresl, P., Rajky, O., Widhalm, G., Ricken, G., Hainfellner, J., Marosi, C., Zielinski, C. C., Birner, P., Preusser, M.
Publicado no Neuro Oncol (2016)

P07.01 18F-fluordesoxyglucose positron emission tomography (FDG-PET) for the detection of the primary lesion in brain metastasis (BM) patients with cancer of unknown primary site (...

Por Wolpert, F., Leske, H., Berghoff, A. S., Rushing, E. J., Andratschke, N., Regli, L., Stupp, R., Kaufmann, P., Preusser, M., Weller, M.
Publicado no Neuro Oncol (2016)

P08.54 Revisiting the,,go or grow” hypothesis in glioma in vivo

Por Karimian Jazi, K., Ratliff, M., Solecki, G., Osswald, M., Jung, E., Berghoff, A., Grosch, J., Bendszus, M., Wick, W., Winkler, F.
Publicado no Neuro Oncol (2016)

Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center

Por Füreder, L. M., Widhalm, G., Gatterbauer, B., Dieckmann, K., Hainfellner, J. A., Bartsch, R., Zielinski, C. C., Preusser, M., Berghoff, A. S.
Publicado no Clin Exp Metastasis (2018)

P08.01 RESPONSE TO T-DM1 IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES (BM)

Por Berghoff, A.S., Bartsch, R., Bergen, E., Rudas, M., Gnant, M., Dieckmann, K., Pinker, K., Zielinski, C.C., Steger, G.G., Preusser, M.
Publicado em 2014

OS7.3 Impact of platelets and coagulation factors on the early steps of the brain metastatic cascade

Por Feinauer, M. J., Berghoff, A. S., Solecki, G., Grosch, J. K., Bauer, A. T., Arteta, J. R., Osswald, M., Schneider, S. W., Wick, W., Winkler, F.
Publicado no Neuro Oncol (2016)

OS7.4 Outcome of patients presenting with brain metastasis as first manifestation of cancer

Por Füreder, L. M., Berghoff, A. S., Gatterbauer, B., Dieckmann, K., Widhalm, G., Hainfellner, J. A., Birner, P., Bartsch, R., Zielinski, C. C., Preusser, M.
Publicado no Neuro Oncol (2016)

Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors

Por Berghoff, A S, Bago-Horvath, Z, Ilhan-Mutlu, A, Magerle, M, Dieckmann, K, Marosi, C, Birner, P, Widhalm, G, Steger, G G, Zielinski, C C, Bartsch, R, Preusser, M
Publicado em 2012